IL116405A - Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses - Google Patents
Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its usesInfo
- Publication number
- IL116405A IL116405A IL11640595A IL11640595A IL116405A IL 116405 A IL116405 A IL 116405A IL 11640595 A IL11640595 A IL 11640595A IL 11640595 A IL11640595 A IL 11640595A IL 116405 A IL116405 A IL 116405A
- Authority
- IL
- Israel
- Prior art keywords
- methoxy
- dione
- hexahydro
- benz
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37941495A | 1995-01-27 | 1995-01-27 | |
US08/463,528 US5597823A (en) | 1995-01-27 | 1995-06-05 | Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
IL116405A0 IL116405A0 (en) | 1996-03-31 |
IL116405A true IL116405A (en) | 2001-09-13 |
Family
ID=27008615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11640595A IL116405A (en) | 1995-01-27 | 1995-12-15 | Hexahydrobenz [E] Transformed Tricyclic Isoindole, Alpha 1 - an antagonistic adrenergic composition containing it and its uses |
Country Status (15)
Country | Link |
---|---|
US (1) | US5597823A (es) |
EP (1) | EP0808318B1 (es) |
JP (1) | JP2001504797A (es) |
KR (1) | KR19980701700A (es) |
AT (1) | ATE194141T1 (es) |
AU (1) | AU705283B2 (es) |
CA (1) | CA2211212A1 (es) |
DE (1) | DE69609051T2 (es) |
DK (1) | DK0808318T3 (es) |
ES (1) | ES2149451T3 (es) |
GR (1) | GR3034485T3 (es) |
IL (1) | IL116405A (es) |
MX (1) | MX9705674A (es) |
PT (1) | PT808318E (es) |
WO (1) | WO1996022992A1 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177430B1 (en) | 1997-03-27 | 2001-01-23 | Pfizer Inc | Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
IL120302A0 (en) * | 1996-03-27 | 1997-06-10 | Pfizer | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
AR008395A1 (es) * | 1996-07-09 | 2000-01-19 | Astra Pharma Prod | Compuesto derivado de pirimidina, composicion farmaceutica que lo comprende, procedimiento para prepararlo, y compuesto intermediario util parallevar a cabo dicho procedimiento. |
US5891882A (en) * | 1996-12-06 | 1999-04-06 | Abbott Laboratories | Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds |
WO1998057638A1 (en) * | 1997-06-18 | 1998-12-23 | Merck & Co., Inc. | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
WO1999048530A1 (en) * | 1998-03-23 | 1999-09-30 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US6133275A (en) * | 1998-05-06 | 2000-10-17 | Abbott Laboratories | 3-phenylpyrrolidine alpha-1 adrenergic compounds |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
JP2002523405A (ja) * | 1998-08-20 | 2002-07-30 | アボット・ラボラトリーズ | レジオ選択的置換ピラジン異性体を製造するための方法 |
RU2224520C2 (ru) | 1998-08-20 | 2004-02-27 | Тояма Кемикал Ко., Лтд. | Азотсодержащие гетероциклические производные карбоксамида или их соли и противовирусные средства, включающие их |
EP1140901A2 (en) * | 1998-12-24 | 2001-10-10 | Aventis Pharmaceuticals Products Inc. | Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
US7497827B2 (en) | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
JP2005104838A (ja) | 2003-01-09 | 2005-04-21 | Tanabe Seiyaku Co Ltd | 縮合フラン化合物 |
US7754709B2 (en) * | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
US7524853B2 (en) * | 2003-06-10 | 2009-04-28 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
US7465739B2 (en) * | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
ATE431351T1 (de) * | 2004-12-13 | 2009-05-15 | Solvay Pharm Gmbh | NEUE SUBSTITUIERTE THIOPHENPYRIMIDINONDERIVATE ALS INHIBITOREN VON 17ß- HYDROXYSTEROIDDEHYDROGENASE |
ES2441873T3 (es) | 2005-05-26 | 2014-02-06 | Aldexa Therapeutics, Inc. | Derivados de quinolina para el tratamiento de enfermedades retinianas |
CA2612419C (en) * | 2005-06-23 | 2017-06-13 | Array Biopharma Inc. | Process for preparing benzimidazole compounds |
AU2006311851A1 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Azaindole compounds and use thereof as phospholipase-A2 inhibitors |
JP5041403B2 (ja) * | 2007-02-02 | 2012-10-03 | 国立大学法人北海道大学 | カフェイン類縁体 |
CA2782015C (en) | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
CN105073714A (zh) | 2012-12-20 | 2015-11-18 | 奥尔德拉医疗公司 | 迫位原醇 |
EP2948149A4 (en) | 2013-01-23 | 2016-12-14 | Aldeyra Therapeutics Inc | BY TOXIC ALDEHYDIC DISEASES AND TREATMENT |
WO2014116593A1 (en) | 2013-01-25 | 2014-07-31 | Aldexa Therapeutics, Inc. | Novel traps in the treatment of macular degeneration |
KR102664994B1 (ko) | 2015-08-21 | 2024-05-13 | 알데이라 테라퓨틱스, 아이엔씨. | 중수소화 화합물 및 이의 용도 |
AU2017264697A1 (en) | 2016-05-09 | 2018-11-22 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
CN110431130A (zh) | 2017-03-16 | 2019-11-08 | 奥尔德拉医疗公司 | 多晶型化合物和其用途 |
US11040039B2 (en) | 2017-10-10 | 2021-06-22 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
WO2020033344A1 (en) | 2018-08-06 | 2020-02-13 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
CN113784954A (zh) | 2019-05-02 | 2021-12-10 | 奥尔德拉医疗公司 | 多晶型化合物和其用途 |
CN112079832A (zh) * | 2020-10-30 | 2020-12-15 | 黑龙江中医药大学 | 一种治疗子宫肌瘤的药物及其制备方法 |
CN114957090B (zh) * | 2021-12-31 | 2023-09-19 | 淮阴师范学院 | 稠合异吲哚衍生物的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
GB9123857D0 (en) * | 1991-11-09 | 1992-01-02 | Smithkline Beecham Plc | Novel compounds |
-
1995
- 1995-06-05 US US08/463,528 patent/US5597823A/en not_active Expired - Fee Related
- 1995-12-15 IL IL11640595A patent/IL116405A/en not_active IP Right Cessation
-
1996
- 1996-01-11 AT AT96903340T patent/ATE194141T1/de not_active IP Right Cessation
- 1996-01-11 PT PT96903340T patent/PT808318E/pt unknown
- 1996-01-11 WO PCT/US1996/000072 patent/WO1996022992A1/en not_active Application Discontinuation
- 1996-01-11 DE DE69609051T patent/DE69609051T2/de not_active Expired - Fee Related
- 1996-01-11 DK DK96903340T patent/DK0808318T3/da active
- 1996-01-11 ES ES96903340T patent/ES2149451T3/es not_active Expired - Lifetime
- 1996-01-11 CA CA002211212A patent/CA2211212A1/en not_active Abandoned
- 1996-01-11 MX MX9705674A patent/MX9705674A/es unknown
- 1996-01-11 JP JP52286796A patent/JP2001504797A/ja active Pending
- 1996-01-11 KR KR1019970705096A patent/KR19980701700A/ko not_active Application Discontinuation
- 1996-01-11 EP EP96903340A patent/EP0808318B1/en not_active Expired - Lifetime
- 1996-01-11 AU AU47457/96A patent/AU705283B2/en not_active Ceased
-
2000
- 2000-09-26 GR GR20000402174T patent/GR3034485T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1996022992A1 (en) | 1996-08-01 |
DE69609051D1 (de) | 2000-08-03 |
EP0808318B1 (en) | 2000-06-28 |
DK0808318T3 (da) | 2000-10-16 |
GR3034485T3 (en) | 2000-12-29 |
ES2149451T3 (es) | 2000-11-01 |
IL116405A0 (en) | 1996-03-31 |
DE69609051T2 (de) | 2001-03-22 |
US5597823A (en) | 1997-01-28 |
ATE194141T1 (de) | 2000-07-15 |
KR19980701700A (ko) | 1998-06-25 |
AU705283B2 (en) | 1999-05-20 |
MX9705674A (es) | 1997-10-31 |
JP2001504797A (ja) | 2001-04-10 |
AU4745796A (en) | 1996-08-14 |
PT808318E (pt) | 2000-12-29 |
CA2211212A1 (en) | 1996-08-01 |
EP0808318A1 (en) | 1997-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0808318B1 (en) | Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists | |
AU694611B2 (en) | Bicyclic substituted hexahydrobenz{e}isoindole alpha-1- adrenergic antagonists | |
AU2015238541B2 (en) | Condensed [1,4]diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors | |
KR101586870B1 (ko) | (디히드로)피롤로[2,1-a]이소퀴놀린 | |
AU626452B2 (en) | Condensed diazepinones | |
PH12015500263B1 (en) | New bicyclic derivatives | |
US5891882A (en) | Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds | |
US5521181A (en) | Bicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonists | |
EP0942911B1 (en) | Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds | |
IE851712L (en) | Pyrazolopyridines | |
IE903279A1 (en) | Condensed diazepinones | |
Esser et al. | Cyclic Guanidines; III1 Synthesis of Novel 8, 13, 15-Triazasteroids and Related Heterocycles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9K | Patent not in force due to non-payment of renewal fees |